| Bioactivity | Levormeloxifene (L-Centchroman) is a selective estrogen receptor modulator (SERM), which prevents and ameliorates postmenopausal osteoporosis. Levormeloxifene causes multiple adverse gynecological effects[1]. |
| CAS | 78994-23-7 |
| Formula | C30H35NO3 |
| Molar Mass | 457.60 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Goldstein SR, et al., Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study. Am J Obstet Gynecol. 2002 Sep;187(3):521-7. |
Levormeloxifene
CAS: 78994-23-7 F: C30H35NO3 W: 457.60
Levormeloxifene (L-Centchroman) is a selective estrogen receptor modulator (SERM), which prevents and ameliorates postme
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.